Top

Journal of Neuroinflammation

Published in:

Open Access 01-12-2022 | Research

Effect of rottlerin on astrocyte phenotype polarization after trimethyltin insult in the dentate gyrus of mice

Authors: Yeonggwang Hwang, Hyoung-Chun Kim, Eun-Joo Shin

Published in: Journal of Neuroinflammation | Issue 1/2022

Abstract

Background

It has been demonstrated that reactive astrocytes can be polarized into pro-inflammatory A1 phenotype or anti-inflammatory A2 phenotype under neurotoxic and neurodegenerative conditions. Microglia have been suggested to play a critical role in astrocyte phenotype polarization by releasing pro- and anti-inflammatory mediators. In this study, we examined whether trimethyltin (TMT) insult can induce astrocyte polarization in the dentate gyrus of mice, and whether protein kinase Cδ (PKCδ) plays a role in TMT-induced astrocyte phenotype polarization.

Methods

Male C57BL/6 N mice received TMT (2.6 mg/kg, i.p.), and temporal changes in the mRNA expression of A1 and A2 phenotype markers were evaluated in the hippocampus. In addition, temporal and spatial changes in the protein expression of C3, S100A10, Iba-1, and p-PKCδ were examined in the dentate gyrus. Rottlerin (5 mg/kg, i.p. × 5 at 12-h intervals) was administered 3–5 days after TMT treatment, and the expression of A1 and A2 transcripts, p-PKCδ, Iba-1, C3, S100A10, and C1q was evaluated 6 days after TMT treatment.

Results

TMT treatment significantly increased the mRNA expression of A1 and A2 phenotype markers, and the increased expression of A1 markers remained longer than that of A2 markers. The immunoreactivity of the representative A1 phenotype marker, C3 and A2 phenotype marker, S100A10 peaked 6 days after TMT insult in the dentate gyrus. While C3 was expressed evenly throughout the dentate gyrus, S100A10 was highly expressed in the hilus and inner molecular layer. In addition, TMT insult induced microglial p-PKCδ expression. Treatment with rottlerin, a PKCδ inhibitor, decreased Iba-1 and C3 expression, but did not affect S100A10 expression, suggesting that PKCδ inhibition attenuates microglial activation and A1 astrocyte phenotype polarization. Consistently, rottlerin significantly reduced the expression of C1q and tumor necrosis factor-α (TNFα), which has been suggested to be released by activated microglia and induce A1 astrocyte polarization.

Conclusion

We demonstrated the temporal and spatial profiles of astrocyte polarization after TMT insult in the dentate gyrus of mice. Taken together, our results suggest that PKCδ plays a role in inducing A1 astrocyte polarization by promoting microglial activation and consequently increasing the expression of pro-inflammatory mediators after TMT insult.

Available only for authorised users

Miller SJ. Astrocyte heterogeneity in the adult central nervous system. Front Cell Neurosci. 2018;12:401. https://doi.org/10.3389/fncel.2018.00401.CrossRefPubMedPubMedCentral

Verkhratsky A, Parpura V, Vardjan N, Zorec R. Physiology of astroglia. Adv Exp Med Biol. 2019;1175:45–91. https://doi.org/10.1007/978-981-13-9913-8_3.CrossRefPubMedPubMedCentral

Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist. 2005;11(5):400–7. https://doi.org/10.1177/1073858405278321.CrossRefPubMed

Pekny M, Pekna M, Messing A, Steinhauser C, Lee JM, Parpura V, et al. Astrocytes: a central element in neurological diseases. Acta Neuropathol. 2016;131(3):323–45. https://doi.org/10.1007/s00401-015-1513-1.CrossRefPubMed

Bylicky MA, Mueller GP, Day RM. Mechanisms of endogenous neuroprotective effects of astrocytes in brain injury. Oxid Med Cell Longev. 2018;2018:6501031. https://doi.org/10.1155/2018/6501031.CrossRefPubMedPubMedCentral

Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312–25. https://doi.org/10.1038/s41593-020-00783-4.CrossRefPubMedPubMedCentral

Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42–52. https://doi.org/10.1186/s40035-020-00221-2.CrossRefPubMedPubMedCentral

Fan YY, Huo J. A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils? Neurochem Int. 2021;148: 105080. https://doi.org/10.1016/j.neuint.2021.105080.CrossRefPubMed

Acioglu C, Li L, Elkabes S. Contribution of astrocytes to neuropathology of neurodegenerative diseases. Brain Res. 2021;1758: 147291. https://doi.org/10.1016/j.brainres.2021.147291.CrossRefPubMed

10.

Ding ZB, Song LJ, Wang Q, Kumar G, Yan YQ, Ma CG. Astrocytes: a double-edged sword in neurodegenerative diseases. Neural Regen Res. 2021;16(9):1702–10. https://doi.org/10.4103/1673-5374.306064.CrossRefPubMedPubMedCentral

11.

Lee Y, Lee S, Chang SC, Lee J. Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention. Arch Pharm Res. 2019;42(5):416–25. https://doi.org/10.1007/s12272-019-01133-0.CrossRefPubMed

12.

Miyamoto N, Magami S, Inaba T, Ueno Y, Hira K, Kijima C, et al. The effects of A1/A2 astrocytes on oligodendrocyte linage cells against white matter injury under prolonged cerebral hypoperfusion. Glia. 2020;68(9):1910–24. https://doi.org/10.1002/glia.23814.CrossRefPubMed

13.

Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32(18):6391–410. https://doi.org/10.1523/JNEUROSCI.6221-11.2012.CrossRefPubMedPubMedCentral

14.

Clark DPQ, Perreau VM, Shultz SR, Brady RD, Lei E, Dixit S, et al. Inflammation in traumatic brain injury: roles for toxic a1 astrocytes and microglial-astrocytic crosstalk. Neurochem Res. 2019;44(6):1410–24. https://doi.org/10.1007/s11064-019-02721-8.CrossRefPubMed

15.

Wang J, Hou Y, Zhang L, Liu M, Zhao J, Zhang Z, et al. Estrogen Attenuates Traumatic Brain Injury by Inhibiting the Activation of Microglia and Astrocyte-Mediated Neuroinflammatory Responses. Mol Neurobiol. 2021;58(3):1052–61. https://doi.org/10.1007/s12035-020-02171-2.CrossRefPubMed

16.

Wei Y, Chen T, Bosco DB, Xie M, Zheng J, Dheer A, et al. The complement C3–C3aR pathway mediates microglia-astrocyte interaction following status epilepticus. Glia. 2021;69(5):1155–69. https://doi.org/10.1002/glia.23955.CrossRefPubMed

17.

Steinberg SF. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem J. 2004;384(Pt 3):449–59. https://doi.org/10.1042/BJ20040704.CrossRefPubMedPubMedCentral

18.

Meng QH, Lou FL, Hou WX, Liu M, Guo H, Zhang XM. Acetylpuerarin reduces inflammation and improves memory function in a rat model of Alzheimer’s disease induced by Abeta1-42. Pharmazie. 2013;68(11):904–8. https://doi.org/10.1691/ph.2013.3571.CrossRefPubMed

19.

Sejimo S, Hossain MS, Akashi K. Scallop-derived plasmalogens attenuate the activation of PKCdelta associated with the brain inflammation. Biochem Biophys Res Commun. 2018;503(2):837–42. https://doi.org/10.1016/j.bbrc.2018.06.084.CrossRefPubMed

20.

Shin EJ, Tran HQ, Nguyen PT, Jeong JH, Nah SY, Jang CG, et al. Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: involvement in oxidative stress, neuroinflammation, and pro-apoptosis-a review. Neurochem Res. 2018;43(1):66–78. https://doi.org/10.1007/s11064-017-2318-5.CrossRefPubMed

21.

Shin EJ, Hwang YG, Sharma N, Tran HQ, Dang DK, Jang CG, et al. Role of protein kinase Cdelta in dopaminergic neurotoxic events. Food Chem Toxicol. 2018;121:254–61. https://doi.org/10.1016/j.fct.2018.09.005.CrossRefPubMed

22.

Kaasinen SK, Goldsteins G, Alhonen L, Janne J, Koistinaho J. Induction and activation of protein kinase C delta in hippocampus and cortex after kainic acid treatment. Exp Neurol. 2002;176(1):203–12. https://doi.org/10.1006/exnr.2002.7919.CrossRefPubMed

23.

Tang FR, Lee WL, Gao H, Chen Y, Loh YT, Chia SC. Expression of different isoforms of protein kinase C in the rat hippocampus after pilocarpine-induced status epilepticus with special reference to CA1 area and the dentate gyrus. Hippocampus. 2004;14(1):87–98. https://doi.org/10.1002/hipo.10156.CrossRefPubMed

24.

Eun SY, Kim EH, Kang KS, Kim HJ, Jo SA, Kim SJ, et al. Cell type-specific upregulation of myristoylated alanine-rich C kinase substrate and protein kinase C-alpha, -beta I, -beta II, and -delta in microglia following kainic acid-induced seizures. Exp Mol Med. 2006;38(3):310–9. https://doi.org/10.1038/emm.2006.37.CrossRefPubMed

25.

Hwang Y, Kim HC, Shin EJ. Repeated exposure to microcystin-leucine-arginine potentiates excitotoxicity induced by a low dose of kainate. Toxicology. 2021;460: 152887. https://doi.org/10.1016/j.tox.2021.152887.CrossRefPubMed

26.

Besser R, Kramer G, Thumler R, Bohl J, Gutmann L, Hopf HC. Acute trimethyltin limbic-cerebellar syndrome. Neurology. 1987;37(6):945–50. https://doi.org/10.1212/wnl.37.6.945.CrossRefPubMed

27.

Kreyberg S, Torvik A, Bjorneboe A, Wiik-Larsen W, Jacobsen D. Trimethyltin poisoning: report of a case with postmortem examination. Clin Neuropathol. 1992;11(5):256–9.PubMed

28.

Feldman RG, White RF, Eriator II. Trimethyltin encephalopathy. Arch Neurol. 1993;50(12):1320–4. https://doi.org/10.1001/archneur.1993.00540120035010.CrossRefPubMed

29.

Brown AW, Aldridge WN, Street BW, Verschoyle RD. The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat. Am J Pathol. 1979;97(1):59–82.PubMedPubMedCentral

30.

Dyer RS, Walsh TJ, Wonderlin WF, Bercegeay M. The trimethyltin syndrome in rats. Neurobehav Toxicol Teratol. 1982;4(2):127–33.PubMed

31.

Wenger GR, McMillan DE, Chang LW. Behavioral effects of trimethyltin in two strains of mice. I. Spontaneous motor activity. Toxicol Appl Pharmacol. 1984;73(1):78–88. https://doi.org/10.1016/0041-008x(84)90055-3.CrossRefPubMed

32.

Segal M. Behavioral and physiological effects of trimethyltin in the rat hippocampus. Neurotoxicology. 1988;9(3):481–9.PubMed

33.

Corvino V, Marchese E, Michetti F, Geloso MC. Neuroprotective strategies in hippocampal neurodegeneration induced by the neurotoxicant trimethyltin. Neurochem Res. 2013;38(2):240–53. https://doi.org/10.1007/s11064-012-0932-9.CrossRefPubMed

34.

Lee S, Yang M, Kim J, Kang S, Kim J, Kim JC, et al. Trimethyltin-induced hippocampal neurodegeneration: A mechanism-based review. Brain Res Bull. 2016;125:187–99. https://doi.org/10.1016/j.brainresbull.2016.07.010.CrossRefPubMed

35.

Chang LW, Wenger GR, McMillan DE, Dyer RS. Species and strain comparison of acute neurotoxic effects of trimethyltin in mice and rats. Neurobehav Toxicol Teratol. 1983;5(3):337–50.PubMed

36.

Fiedorowicz A, Figiel I, Kaminska B, Zaremba M, Wilk S, Oderfeld-Nowak B. Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure. Brain Res. 2001;912(2):116–27. https://doi.org/10.1016/s0006-8993(01)02675-0.CrossRefPubMed

37.

Shin EJ, Nam Y, Tu TH, Lim YK, Wie MB, Kim DJ, et al. Protein kinase Cdelta mediates trimethyltin-induced neurotoxicity in mice in vivo via inhibition of glutathione defense mechanism. Arch Toxicol. 2016;90(4):937–53. https://doi.org/10.1007/s00204-015-1516-7.CrossRefPubMed

38.

Hwang Y, Kim HC, Shin EJ. Enhanced neurogenesis is involved in neuroprotection provided by rottlerin against trimethyltin-induced delayed apoptotic neuronal damage. Life Sci. 2020;262: 118494. https://doi.org/10.1016/j.lfs.2020.118494.CrossRefPubMed

39.

Cordeau PJ, Lalancette-Hébert M, Weng YC, Kriz J. Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury. Stroke. 2008;39(3):935–42. https://doi.org/10.1161/STROKEAHA.107.501460.CrossRefPubMed

40.

Kato TA, Hayakawa K, Monji A, Kanba S. Missing and possible link between neuroendocrine factors, neuropsychiatric disorders, and microglia. Front Integr Neurosci. 2013;7:53. https://doi.org/10.3389/fnint.2013.00053.CrossRefPubMedPubMedCentral

41.

Xiong X, Xu L, Wei L, White RE, Ouyang YB, Giffard RG. IL-4 is required for sex differences in vulnerability to focal ischemia in mice. Stroke. 2015;46(8):2271–6. https://doi.org/10.1161/STROKEAHA.115.008897.CrossRefPubMedPubMedCentral

42.

Villa A, Vegeto E, Poletti A, Maggi A. Estrogens, neuroinflammation, and neurodegeneration. Endocr Rev. 2016;37(4):372–402. https://doi.org/10.1210/er.2016-1007.CrossRefPubMedPubMedCentral

43.

Liao TY, Tzeng WY, Wu HH, Cherng CG, Wang CY, Hu SS, et al. Rottlerin impairs the formation and maintenance of psychostimulant-supported memory. Psychopharmacology. 2016;233(8):1455–65. https://doi.org/10.1007/s00213-016-4251-8.CrossRefPubMed

44.

Liu M, Shin EJ, Dang DK, Jin CH, Lee PH, Jeong JH, et al. Trichloroethylene and parkinson’s disease: risk assessment. Mol Neurobiol. 2018;55(7):6201–14. https://doi.org/10.1007/s12035-017-0830-x.CrossRefPubMed

45.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. https://doi.org/10.1006/meth.2001.1262.CrossRefPubMed

46.

Dang DK, Shin EJ, Nam Y, Ryoo S, Jeong JH, Jang CG, et al. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK. J Neuroinflammation. 2016;13:12–x. https://doi.org/10.1186/s12974-016-0478-x.CrossRefPubMedPubMedCentral

47.

Young K, Morrison H. Quantifying Microglia Morphology from Photomicrographs of Immunohistochemistry Prepared Tissue Using ImageJ. J Vis Exp. 2018;136: e57648. https://doi.org/10.3791/57648.CrossRef

48.

Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481–7. https://doi.org/10.1038/nature21029.CrossRefPubMedPubMedCentral

49.

Fujita A, Yamaguchi H, Yamasaki R, Cui Y, Matsuoka Y, Yamada KI, et al. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson’s disease animal model. J Neuroinflammation. 2018;15(1):227. https://doi.org/10.1186/s12974-018-1251-0.CrossRefPubMedPubMedCentral

50.

Jonas RA, Yuan TF, Liang YX, Jonas JB, Tay DK, Ellis-Behnke RG. The spider effect: morphological and orienting classification of microglia in response to stimuli in vivo. PLoS ONE. 2012;7(2): e30763. https://doi.org/10.1371/journal.pone.0030763.CrossRefPubMedPubMedCentral

51.

Holloway OG, Canty AJ, King AE, Ziebell JM. Rod microglia and their role in neurological diseases. Semin Cell Dev Biol. 2019;94:96–103. https://doi.org/10.1016/j.semcdb.2019.02.005.CrossRefPubMed

52.

Stephan AH, Madison DV, Mateos JM, Fraser DA, Lovelett EA, Coutellier L, et al. A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci. 2013;33(33):13460–74. https://doi.org/10.1523/JNEUROSCI.1333-13.2013.CrossRefPubMedPubMedCentral

53.

Zhang L, Guo K, Zhou J, Zhang X, Yin S, Peng J, et al. Ponesimod protects against neuronal death by suppressing the activation of A1 astrocytes in early brain injury after experimental subarachnoid hemorrhage. J Neurochem. 2021;158(4):880–97. https://doi.org/10.1111/jnc.15457.CrossRefPubMed

54.

Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 1999;23(2):297–308. https://doi.org/10.1016/s0896-6273(00)80781-3.CrossRefPubMed

55.

Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain. 2006;129(Pt 10):2761–72. https://doi.org/10.1093/brain/awl165.CrossRefPubMed

56.

Katsouri L, Birch AM, Renziehausen AWJ, Zach C, Aman Y, Steeds H, et al. Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer’s disease. Glia. 2020;68(5):1017–30. https://doi.org/10.1002/glia.23759.CrossRefPubMed

57.

Thom M. Review: Hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol. 2014;40(5):520–43. https://doi.org/10.1111/nan.12150.CrossRefPubMedPubMedCentral

58.

Cho J, Lee SH, Seo JH, Kim HS, Ahn JG, Kim SS, et al. Increased expression of phosphatase and tensin homolog in reactive astrogliosis following intracerebroventricular kainic acid injection in mouse hippocampus. Neurosci Lett. 2002;334(2):131–4. https://doi.org/10.1016/s0304-3940(02)01122-9.CrossRefPubMed

59.

Shapiro LA, Wang L, Ribak CE. Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia. 2008;49(Suppl 2):33–41. https://doi.org/10.1111/j.1528-1167.2008.01491.x.CrossRefPubMed

60.

Drexel M, Preidt AP, Sperk G. Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex. Neuropharmacology. 2012;63(5):806–17. https://doi.org/10.1016/j.neuropharm.2012.06.009.CrossRefPubMedPubMedCentral

61.

Kim H, Bing G, Jhoo W, Ko KH, Kim WK, Suh JH, et al. Changes of hippocampal Cu/Zn-superoxide dismutase after kainate treatment in the rat. Brain Res. 2000;853(2):215–26. https://doi.org/10.1016/s0006-8993(99)02254-4.CrossRefPubMed

62.

Kim HC, Jhoo WK, Kim WK, Suh JH, Shin EJ, Kato K, et al. An immunocytochemical study of mitochondrial manganese-superoxide dismutase in the rat hippocampus after kainate administration. Neurosci Lett. 2000;281(1):65–8. https://doi.org/10.1016/s0304-3940(99)00969-6.CrossRefPubMed

63.

Shin EJ, Suh SK, Lim YK, Jhoo WK, Hjelle OP, Ottersen OP, et al. Ascorbate attenuates trimethyltin-induced oxidative burden and neuronal degeneration in the rat hippocampus by maintaining glutathione homeostasis. Neuroscience. 2005;133(3):715–27. https://doi.org/10.1016/j.neuroscience.2005.02.030.CrossRefPubMed

64.

Shin EJ, Ko KH, Kim WK, Chae JS, Yen TP, Kim HJ, et al. Role of glutathione peroxidase in the ontogeny of hippocampal oxidative stress and kainate seizure sensitivity in the genetically epilepsy-prone rats. Neurochem Int. 2008;52(6):1134–47. https://doi.org/10.1016/j.neuint.2007.12.003.CrossRefPubMed

65.

Shin EJ, Jeong JH, Chung CK, Kim DJ, Wie MB, Park ES, et al. Ceruloplasmin is an endogenous protectant against kainate neurotoxicity. Free Radic Biol Med. 2015;84:355–72. https://doi.org/10.1016/j.freeradbiomed.2015.03.031.CrossRefPubMed

66.

Fedele DE, Gouder N, Guttinger M, Gabernet L, Scheurer L, Rulicke T, et al. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain. 2005;128(Pt 10):2383–95. https://doi.org/10.1093/brain/awh555.CrossRefPubMed

67.

Robel S, Buckingham SC, Boni JL, Campbell SL, Danbolt NC, Riedemann T, et al. Reactive astrogliosis causes the development of spontaneous seizures. J Neurosci. 2015;35(8):3330–45. https://doi.org/10.1523/JNEUROSCI.1574-14.2015.CrossRefPubMedPubMedCentral

68.

Lee S, Yang M, Kim J, Kim J, Son Y, Kwon S, et al. Nestin expression and glial response in the hippocampus of mice after trimethyltin treatment. Acta Histochem. 2014;116(8):1276–88. https://doi.org/10.1016/j.acthis.2014.07.009.CrossRefPubMed

69.

Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WG, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis. 2007;26(3):497–511. https://doi.org/10.1016/j.nbd.2007.01.015.CrossRefPubMed

70.

Kharatishvili I, Shan ZY, She DT, Foong S, Kurniawan ND, Reutens DC. MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy. Brain Struct Funct. 2014;219(2):683–706. https://doi.org/10.1007/s00429-013-0528-4.CrossRefPubMed

71.

Atkinson C, Zhu H, Qiao F, Varela JC, Yu J, Song H, et al. Complement-dependent P-selectin expression and injury following ischemic stroke. J Immunol. 2006;177(10):7266–74. https://doi.org/10.4049/jimmunol.177.10.7266.CrossRefPubMed

72.

Ducruet AF, Sosunov SA, Zacharia BE, Gorski J, Yeh ML, Derosa P, et al. The neuroprotective effect of genetic mannose-binding lectin deficiency is not sustained in the sub-acute phase of stroke. Transl Stroke Res. 2011;2(4):588–99. https://doi.org/10.1007/s12975-011-0104-2.CrossRefPubMedPubMedCentral

73.

Sartain SE, Turner NA, Moake JL. Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells. J Biol Chem. 2018;293(19):7195–208. https://doi.org/10.1074/jbc.RA118.002639.CrossRefPubMedPubMedCentral

74.

Clarke LE, Liddelow SA, Chakraborty C, Munch AE, Heiman M, Barres BA. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci USA. 2018;115(8):E1896-905. https://doi.org/10.1073/pnas.1800165115.CrossRefPubMedPubMedCentral

75.

Neal M, Luo J, Harischandra DS, Gordon R, Sarkar S, Jin H, et al. Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes. Glia. 2018;66(10):2137–57. https://doi.org/10.1002/glia.23467.CrossRefPubMedPubMedCentral

76.

Reichenbach N, Delekate A, Plescher M, Schmitt F, Krauss S, Blank N, et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer’s disease model. EMBO Mol Med. 2019. https://doi.org/10.15252/emmm.201809665.CrossRefPubMedPubMedCentral

77.

Zhang Q, Liu C, Shi R, Zhou S, Shan H, Deng L, et al. Blocking C3d⁺/GFAP⁺ A1 astrocyte conversion with semaglutide attenuates blood-brain barrier disruption in mice after ischemic stroke. Aging Dis. 2022;13(3):943–59. https://doi.org/10.14336/AD.2021.1029.CrossRefPubMedPubMedCentral

78.

Li T, Liu T, Chen X, Li L, Feng M, Zhang Y, et al. Microglia induce the transformation of A1/A2 reactive astrocytes via the CXCR7/PI3K/Akt pathway in chronic post-surgical pain. J Neuroinflammation. 2020;17(1):211–5. https://doi.org/10.1186/s12974-020-01891-5.CrossRefPubMedPubMedCentral

79.

Litvinchuk A, Wan YW, Swartzlander DB, Chen F, Cole A, Propson NE, et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer’s disease. Neuron. 2018;100(6):1337-1353.e5. https://doi.org/10.1016/j.neuron.2018.10.031.CrossRefPubMedPubMedCentral

80.

Li SM, Li B, Zhang L, Zhang GF, Sun J, Ji MH, et al. A complement-microglial axis driving inhibitory synapse related protein loss might contribute to systemic inflammation-induced cognitive impairment. Int Immunopharmacol. 2020;87: 106814. https://doi.org/10.1016/j.intimp.2020.106814.CrossRefPubMed

81.

Zheng J, Lu J, Mei S, Wu H, Sun Z, Fang Y, et al. Ceria nanoparticles ameliorate white matter injury after intracerebral hemorrhage: microglia-astrocyte involvement in remyelination. J Neuroinflammation. 2021;18(1):43–6. https://doi.org/10.1186/s12974-021-02101-6.CrossRefPubMedPubMedCentral

82.

Minogue AM. Role of infiltrating monocytes/macrophages in acute and chronic neuroinflammation: effects on cognition, learning and affective behaviour. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79(Pt A):15–8. https://doi.org/10.1016/j.pnpbp.2017.02.008.CrossRefPubMed

83.

Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. https://doi.org/10.1186/s12974-019-1516-2.CrossRefPubMedPubMedCentral

84.

Gliem M, Mausberg AK, Lee J, Simiantonakis I, van Rooijen N, Hartung H, et al. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol. 2012;71(6):743–52. https://doi.org/10.1002/ana.23529.CrossRefPubMed

85.

Rajan WD, Wojtas B, Gielniewski B, Gieryng A, Zawadzka M, Kaminska B. Dissecting functional phenotypes of microglia and macrophages in the rat brain after transient cerebral ischemia. Glia. 2019;67(2):232–45. https://doi.org/10.1002/glia.23536.CrossRefPubMed

86.

Mishra SK, Kumar BSH, Khushu S, Singh AK, Gangenahalli G. Early monitoring and quantitative evaluation of macrophage infiltration after experimental traumatic brain injury: a magnetic resonance imaging and flow cytometric analysis. Mol Cell Neurosci. 2017;78:25–34. https://doi.org/10.1016/j.mcn.2016.11.008.CrossRefPubMed

87.

Abe N, Choudhury ME, Watanabe M, Kawasaki S, Nishihara T, Yano H, et al. Comparison of the detrimental features of microglia and infiltrated macrophages in traumatic brain injury: a study using a hypnotic bromovalerylurea. Glia. 2018;66(10):2158–73. https://doi.org/10.1002/glia.23469.CrossRefPubMed

88.

Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K, et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci. 2011;31(11):4037–50. https://doi.org/10.1523/JNEUROSCI.6210-10.2011.CrossRefPubMedPubMedCentral

89.

Feng L, Murugan M, Bosco DB, Liu Y, Peng J, Worrell GA, et al. Microglial proliferation and monocyte infiltration contribute to microgliosis following status epilepticus. Glia. 2019;67(8):1434–48. https://doi.org/10.1002/glia.23616.CrossRefPubMedPubMedCentral

90.

Rossi A, Murta V, Auzmendi J, Ramos AJ. Early gabapentin treatment during the latency period increases convulsive threshold, reduces microglial activation and macrophage infiltration in the lithium-pilocarpine model of epilepsy. Pharmaceuticals (Basel). 2017. https://doi.org/10.3390/ph10040093.CrossRefPubMedCentral

91.

Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, et al. Protein kinase Cdelta upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson’s disease. Neurobiol Dis. 2016;93:96–114. https://doi.org/10.1016/j.nbd.2016.04.008.CrossRefPubMedPubMedCentral

92.

Sharma S, Carlson S, Puttachary S, Sarkar S, Showman L, Putra M, et al. Role of the Fyn-PKCdelta signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy. Neurobiol Dis. 2018;110:102–21. https://doi.org/10.1016/j.nbd.2017.11.008.CrossRefPubMed

93.

Shin EJ, Shin SW, Nguyen TT, Park DH, Wie MB, Jang CG, et al. Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cdelta gene. Mol Neurobiol. 2014;49(3):1400–21. https://doi.org/10.1007/s12035-013-8617-1.CrossRefPubMed

94.

Zhang HY, Wang Y, He Y, Wang T, Huang XH, Zhao CM, et al. A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment. J Neuroinflammation. 2020;17(1):200–9. https://doi.org/10.1186/s12974-020-01871-9.CrossRefPubMedPubMedCentral

95.

Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, et al. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death Dis. 2020;11(5):377. https://doi.org/10.1038/s41419-020-2565-2.CrossRefPubMedPubMedCentral

96.

Shiow LR, Favrais G, Schirmer L, Schang AL, Cipriani S, Andres C, et al. Reactive astrocyte COX2-PGE2 production inhibits oligodendrocyte maturation in neonatal white matter injury. Glia. 2017;65(12):2024–37. https://doi.org/10.1002/glia.23212.CrossRefPubMedPubMedCentral

97.

Qian D, Li L, Rong Y, Liu W, Wang Q, Zhou Z, et al. Blocking Notch signal pathway suppresses the activation of neurotoxic A1 astrocytes after spinal cord injury. Cell Cycle. 2019;18(21):3010–29. https://doi.org/10.1080/15384101.2019.1667189.CrossRefPubMedPubMedCentral

Title: Effect of rottlerin on astrocyte phenotype polarization after trimethyltin insult in the dentate gyrus of mice
Authors: Yeonggwang Hwang
Hyoung-Chun Kim
Eun-Joo Shin
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2022
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/s12974-022-02507-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of rottlerin on astrocyte phenotype polarization after trimethyltin insult in the dentate gyrus of mice

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

Recruitment of α4β7 monocytes and neutrophils to the brain in experimental colitis is associated with elevated cytokines and anxiety-like behavior

Activation of peripheral TRPM8 mitigates ischemic stroke by topically applied menthol

Correction to: Nos2−/− mice infected with M. tuberculosis develop neurobehavioral changes and immunopathology mimicking human central nervous system tuberculosis

Synaptic loss and progression in mice infected with Angiostrongylus cantonensis in the early stage

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway